Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Shenyang Xingqi Pharmaceutical (300573 CH)
Watchlist
38
Analysis
Health Care
•
China
Shenyang Xingqi Pharmaceutical Co., Ltd. is a pharmaceutical company. The Company researches, produces, and distributes ophthalmic medicines including anti-bacterial products, allergy medicines, cataract preventions, and glaucoma treatments.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Shenyang Xingqi Pharmaceutical
•
08 May 2024 06:10
ChiNext/​​​ChiNext50 Index Rebalance Preview: Outperformance Continues
There could be 7 changes for the Chinext and 5 changes for the Chinext50. There are 6 overlapping stocks and those have the largest flows. The...
Brian Freitas
Follow
557 Views
Share
bullish
•
CSPC Innovation Pharmaceutical-A
•
06 May 2024 20:23
Quiddity Leaderboard ChiNext & ChiNext 50 Jun 24: Bull-Bear Hot Streak Continues; Some Surprises
The Bullish Names have outperformed the Bearish Names by +17.7% since I published my last ChiNext insight on 10th April 2024.
Janaghan Jeyakumar, CFA
Follow
494 Views
Share
bullish
•
Shenyang Xingqi Pharmaceutical
•
18 Apr 2024 05:50
ChiNext/​​​ChiNext50 Index Rebalance Preview: Plenty of Overlap Between the Indices
Nearing the end of the review period, we forecast 8 changes for the ChiNext Index (SZ399006 INDEX) and 5 changes for the ChiNext 50 Index in June...
Brian Freitas
Follow
754 Views
Share
bullish
•
CSPC Innovation Pharmaceutical-A
•
10 Apr 2024 17:39
Quiddity Leaderboard ChiNext & ChiNext 50 Jun 24: Bullish Names Outperform Bearish Names Again
The Bullish Names have outperformed the Bearish Names in successive insights. There were 5.75% and 4.18% outperformances in the periods between Mid...
Janaghan Jeyakumar, CFA
Follow
765 Views
Share
bullish
•
CSPC Innovation Pharmaceutical-A
•
13 Mar 2024 17:56
Quiddity Leaderboard ChiNext & ChiNext 50 Jun 24: Multiple Changes to Expectations; US$481mn One-Way
I estimate the one-way index flows for ChiNext and ChiNext 50 to collectively be around US$481mn. Three names have double inclusions expected and...
Janaghan Jeyakumar, CFA
Follow
614 Views
Share
First
Previous
3
4
5
6
7
8
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x